5 Best Peptides for Hypoactive Sexual Desire Disorder (HSDD)
A small but meaningful set of peptides has emerged as the primary compounds people reach for when addressing Hypoactive Sexual Desire Disorder, ranging from PT-141 (bremelanotide), the only peptide with FDA approval for this condition, to investigational options like Kisspeptin-10 and Orenetide that have early clinical data behind them, to adjunct and community-discussed compounds where the picture is more mixed. This guide covers five peptides people actually use or are actively discussing for HSDD, with each compound's evidence stated honestly in plain language. The entries are ordered by how prominently each compound appears in research and documented real-world use, not as a recommendation of one over another, and the personalized decision belongs in a conversation with a qualified provider, not in a listicle.
